Terry and Garry dive into the fascinating world of GLP-1 receptor agonists, those tiny molecules that can be both a blessing and a potential risk factor when it comes to anesthesia. In this episode, we're going embark on a journey through the world of diabetes management, how it intersects with the realm of anesthesia and what the implications are for providers in the operating room.

And in the perioperative period, we're going to shine a spotlight on these new agents, explore their effects, and we're going to discuss the challenges they present to our CRNA colleagues.

Here’s some of what we discuss in this episode:

• How SGLT2 inhibitors help with diabetes management.

Visit us online and get show resources here: https://beyondthemaskpodcast.com/

Get the CE Certificate here: https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf

Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246